Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 28, 2010

View Archived Issues

GO-CoA-Tat controls glucose and weight in preclinical study

Merck & Co. identifies novel glucocorticoid receptor modulators

Asymmetrical CADA analogue VGD-020 displays improved potency against CD4

In vitro data support potential benefits of TT-30 in complement-mediated diseases

New CREB-1 inhibitor XX-650-23 shows promise to treat AML

Pfizer identifies new GPR119 agonists

New antagonists of protease-activated PAR1 receptor claimed

Leo Pharma claims new positive modulators of calcium-sensing CaS receptor

Vertex Pharma patents new inhibitors of hepatocyte growth factor receptor

Gel formulation of IQP-0528 plus tenofovir evaluated in vitro as HIV therapy

Pro-Pharmaceuticals and Mount Sinai School of Medicine to evaluate galectin-targeting agents

King Pharmaceuticals resubmits Remoxy NDA to FDA

Degludec improves long-term glycemic control in phase IIIa diabetes trials

Exiqon offers services for microRNA biomarker screening and diagnostic assay development

AVI BioPharma advances Duchenne's muscular dystrophy program

Transition Therapeutics and Elan modify ELND-005 collaboration agreement

Cephalon discontinues development of Nuvigil for jet lag

FDA reports on ongoing safety review of somatropin

European release of Xpert Flu test for influenza A, B and 2009 H1N1 strain

Vicus begins phase II trial of VT-122 in advanced HCC

Repros completes preclinical studies of vaginal Proellex formulation

European sale of Ruconest begins in Denmark and Norway

EMA to review Allos' MAA for Folotyn in relapsed or refractory PTCL

Emergent BioSolutions begins phase I trial of anthrax vaccine NuThrax

Intellect Neurosciences reports phase Ib data on Alzeimer's disease candidate OX1

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...